1. Home
  2. TENX vs VNCE Comparison

TENX vs VNCE Comparison

Compare TENX & VNCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • VNCE
  • Stock Information
  • Founded
  • TENX 1967
  • VNCE 2002
  • Country
  • TENX United States
  • VNCE United States
  • Employees
  • TENX N/A
  • VNCE N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • VNCE Clothing/Shoe/Accessory Stores
  • Sector
  • TENX Health Care
  • VNCE Consumer Discretionary
  • Exchange
  • TENX Nasdaq
  • VNCE Nasdaq
  • Market Cap
  • TENX 25.0M
  • VNCE 20.2M
  • IPO Year
  • TENX N/A
  • VNCE 2013
  • Fundamental
  • Price
  • TENX $5.99
  • VNCE $1.43
  • Analyst Decision
  • TENX Strong Buy
  • VNCE Strong Buy
  • Analyst Count
  • TENX 3
  • VNCE 4
  • Target Price
  • TENX $15.00
  • VNCE $4.13
  • AVG Volume (30 Days)
  • TENX 15.7K
  • VNCE 18.2K
  • Earning Date
  • TENX 08-13-2025
  • VNCE 09-10-2025
  • Dividend Yield
  • TENX N/A
  • VNCE N/A
  • EPS Growth
  • TENX N/A
  • VNCE N/A
  • EPS
  • TENX N/A
  • VNCE N/A
  • Revenue
  • TENX N/A
  • VNCE $292,214,000.00
  • Revenue This Year
  • TENX N/A
  • VNCE $1.93
  • Revenue Next Year
  • TENX N/A
  • VNCE $4.91
  • P/E Ratio
  • TENX N/A
  • VNCE N/A
  • Revenue Growth
  • TENX N/A
  • VNCE 1.46
  • 52 Week Low
  • TENX $3.25
  • VNCE $1.02
  • 52 Week High
  • TENX $7.89
  • VNCE $6.89
  • Technical
  • Relative Strength Index (RSI)
  • TENX 51.19
  • VNCE 42.58
  • Support Level
  • TENX $5.88
  • VNCE $1.43
  • Resistance Level
  • TENX $6.02
  • VNCE $1.50
  • Average True Range (ATR)
  • TENX 0.13
  • VNCE 0.08
  • MACD
  • TENX -0.01
  • VNCE -0.01
  • Stochastic Oscillator
  • TENX 70.37
  • VNCE 50.00

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About VNCE Vince Holding Corp.

Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.

Share on Social Networks: